title: Reduced intratesticular testosterone concentration alters the polymerization state of the Sertoli cell intermediate filament cytoskeleton by degradation of vimentin.
abstract: The Sertoli cell intermediate filament cytoskeleton is composed of the type III family member vimentin. The distribution of Sertoli cell vimentin varies with the stage of spermatogenesis, with shortening of the filaments at stages VII-VIII, the stages of spermiation. Experimental reduction in intratesticular testosterone (T) concentration also results in the sloughing of advanced spermatids from the Sertoli cells, as well as in the apoptotic death of spermatocytes. We hypothesized that alteration of the distribution of Sertoli cell vimentin might play a role in the loss of germ cells that occurs in response to reduced intratesticular T. To test this hypothesis, intratesticular T was reduced by implanting LH-suppressive SILASTIC brand capsules containing T and estradiol into adult rats for 8 wk. Immunohistochemical analyses revealed that, in response to the implants, the vimentin cytoskeleton collapsed around the Sertoli cell nuclei at all stages of the cycle, losing the extensive branching and structure normally seen at most stages of the cycle. Western blots of isolated Sertoli cells revealed that protein levels did not differ significantly between control and T- and estradiol-treated rats. However, Sertoli cell fractions containing the vimentin monomer revealed that vimentin was cleaved into four to five fragments in Sertoli cells in response to the implants, suggestive of proteolysis. These results indicate that, in response to reduced intratesticular T, the vimentin cytoskeleton of the Sertoli cell collapses to a perinuclear localization, and suggest that this collapse is associated with, and perhaps caused by, the degradation of the vimentin monomer rather than by loss of its expression.
authors.affiliation: Division of Reproductive Biology, Department of Biochemistry and Molecular Biology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland 2120, USA. mshow@jhsph.edu.
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Show
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Anway
authors.forename: Janet S
authors.initials: JS
authors.lastname: Folmer
authors.forename: Barry R
authors.initials: BR
authors.lastname: Zirkin
mesh_terms: D000728:Androgens / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D004343:Drug Implants; D004958:Estradiol / Q000494:pharmacology; D007382:Intermediate Filaments / Q000378:metabolism*; D008297:Male; D008870:Microtubules / Q000378:metabolism; D011108:Polymers; D051381:Rats; D017207:Rats, Sprague-Dawley; D012708:Sertoli Cells / Q000378:metabolism*; D013737:Testis / Q000166:cytology / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism* / Q000494:pharmacology; D014746:Vimentin / Q000378:metabolism*
chemical_list: D000728:Androgens; D004343:Drug Implants; D011108:Polymers; D014746:Vimentin; D013739:Testosterone; D004958:Estradiol